Michael J Pontecorvo

A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia

Stephen Salloway, Sergey Shcherbinin, Mark A Mintun, 2019, Brain : a journal of neurology.

Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.

Val J Lowe, Stephen Salloway, Patricia Aldea, 2020, JAMA neurology.

Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.

Kewei Chen, Eric M Reiman, Napatkamon Ayutyanont, 2011, Archives of neurology.